We organize every Q-submission around specific workstreams so you get targeted FDA feedback, not generic responses.
Strategy & Questions
-
Regulatory pathway & classification: product code confirmation, De Novo vs. 510(k)/PMA logic, combination product pathways, accessory determinations
-
Substantial equivalence / De Novo rationale: predicate selection, technological differences, bridging strategy
-
Clinical & performance evidence: need for studies, endpoint selection, control/arm choice, safety monitoring, real-world data
-
Bench & analytical plans: biocompatibility, sterilization, stability, EMC/electrical safety, software validation scope
-
Human factors & usability: study triggers, critical tasks, summative study design, residual risk rationale
-
Software/SaMD & cybersecurity: IEC 62304 class, algorithm change control, SBOM, vulnerability management
-
IVD specifics: performance study design, specimen handling, controls, method comparisons
-
Labeling & indications: claims language, special controls, patient labeling, home-use considerations
-
Evidence & Materials
-
Briefing package: device description, risk summary, prior testing, specific feedback requests
-
Study synopses & protocols: clinical, performance, or bench outlines with endpoints and acceptance criteria
-
Comparative analyses: predicate/competitive matrices, hazard analyses, usability risk tables, software/data flow maps
-
Readiness exhibits: draft labeling, IFUs, cleaning/sterilization flow, biocompatibility gap tables, cybersecurity plans
-